Clinical Trial Update: Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer [Phase 1]

View source ↗

Summary

This is a completed Phase I/Ib trial evaluating paclitaxel in combination with VS-6063 (defactinib) in patients with advanced ovarian cancer. The report covers …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• VS-6063 (defactinib)

Snippet

Sponsor: Verastem, Inc. | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED